PW Medtech Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,828	1,803	1,682	1,590	1,382	2,285
Trading Asset Securities	-	5	5.15	4.9	5.63	127
Cash & Short-Term Investments	1,828	1,808	1,687	1,595	1,388	2,412
Cash Growth	2.79%	7.16%	5.81%	14.92%	-42.47%	41.72%
Accounts Receivable	67.15	98.27	92.9	109.72	89.25	90.67
Other Receivables	44.08	44.06	51.53	55.17	51.02	48.54
Receivables	111.22	382.33	264.42	284.88	406.57	139.21
Inventory	170.85	145.2	120.28	136.61	132.23	33.18
Other Current Assets	36.35	25.82	22.4	15.54	19.76	9.12
Total Current Assets	2,146	2,361	2,094	2,032	1,946	2,593
Property, Plant & Equipment	924.7	935.5	922.02	933.01	958.64	627.74
Long-Term Investments	58.26	70.69	46.54	61.28	90.33	10
Goodwill	564.09	564.09	564.09	564.09	564.09	160.75
Other Intangible Assets	992.91	952.85	1,018	363.05	393.12	13.93
Long-Term Accounts Receivable	-	-	-	-	6.9	-
Long-Term Deferred Tax Assets	9.37	9.82	10.13	10.29	23.02	23.33
Long-Term Deferred Charges	-	65.54	50.53	733.94	699.33	-
Other Long-Term Assets	269.92	275.58	275.61	274.82	307.6	306
Total Assets	5,146	5,235	5,161	5,152	4,989	3,915

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	43.51	58.79	41.79	36.79	27.84	10.58
Accrued Expenses	47.96	57.66	57.47	47.73	55.57	36.58
Short-Term Debt	15	15	-	-	-	-
Current Portion of Leases	2.44	2.25	1.7	0.76	3.11	2.44
Current Income Taxes Payable	12.71	14.54	17.04	10.66	26.59	5.56
Current Unearned Revenue	44.22	31.36	21.09	8.89	13.59	0.64
Other Current Liabilities	63.1	37.19	38.36	44.44	41.14	48.68
Total Current Liabilities	228.94	216.8	177.44	149.26	167.85	104.47
Long-Term Debt	-	-	5.8	-	-	-
Long-Term Leases	3.6	4.75	4.58	0.37	1.13	-
Long-Term Unearned Revenue	20.2	20.86	21.31	22.72	23.11	16.01
Long-Term Deferred Tax Liabilities	134.49	139.11	148.44	154.71	159.47	2.16
Total Liabilities	387.24	381.52	357.56	327.06	351.56	122.64

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.88	0.9	0.94	0.96	0.96	0.97
Additional Paid-In Capital	1,360	1,393	1,456	1,490	1,490	1,493
Retained Earnings	2,131	2,141	2,177	2,161	2,026	1,920
Treasury Stock	-10.22	-2.75	-46.8	-	-	-
Comprehensive Income & Other	407.36	418.45	383.64	392.77	428.84	378.98
Total Common Equity	3,889	3,950	3,971	4,044	3,945	3,792
Minority Interest	869.31	903.26	831.97	780.64	692.33	-
Shareholders' Equity	4,758	4,854	4,803	4,825	4,638	3,792
Total Liabilities & Equity	5,146	5,235	5,161	5,152	4,989	3,915

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	21.04	22	12.07	1.13	4.24	2.44
Net Cash (Debt)	1,807	1,786	1,675	1,593	1,383	2,409
Net Cash Growth	2.77%	6.61%	5.12%	15.19%	-42.59%	44.16%
Net Cash Per Share	1.21	1.18	1.09	1.02	0.88	1.54
Filing Date Shares Outstanding	1,433	1,472	1,487	1,566	1,566	1,569
Total Common Shares Outstanding	1,433	1,472	1,487	1,566	1,566	1,569
Working Capital	1,918	2,144	1,917	1,882	1,778	2,489
Book Value Per Share	2.71	2.68	2.67	2.58	2.52	2.42
Tangible Book Value	2,332	2,434	2,390	3,117	2,988	3,618
Tangible Book Value Per Share	1.63	1.65	1.61	1.99	1.91	2.31
Buildings	-	673.99	663.18	643.81	637.14	520.34
Machinery	-	501.45	456.6	411.49	359.46	112.77
Construction In Progress	-	64.09	100.22	143.77	162.31	93.53
Leasehold Improvements	-	119.24	67.78	35.28	32.89	8.79